Bausch + Lomb Reviews

Director levels can’t seem to align or have the expertise and skills to generate a plan, agree to it, and execute. Management can’t motivate personnel and is clueless of what modern compliant pharmaceutical operations should look like. Asking Valeant millions without a clear understanding on what the actual site priorities and needs are. Continuous backlog, poor or mindless utilization of resources and no idea on risk mgmt. Another FDA 483 is imminent... data integrity, GMP and GLP disregard.

after spun-off from Bausch Health, started to be more chaotic than before processes are not defined, responsibilities are not clear extremely lean resourced and as a consequence, the workload is very heavy no communication from management on the long-term business plan working with different ERP systems can be confusing for many people salary across the supply chain is below the market value